NCT06783894 Elliptical Physical Activity and Sexual Dysfunction in Males With Irritable Bowel Syndrome
| NCT ID | NCT06783894 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Irritable Bowel Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-01-12 |
| Primary Completion | 2025-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-01-12 with a primary completion date of 2025-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
psychological disturbances resulting from irritable bowel syndrome causes sexual dysfunction in men such as weak erection of penis. The different exercise forms are important in improving symptoms of this syndrome and exercise also may improve sexual dysfunction in men
Eligibility Criteria
Inclusion Criteria: * men with irritable bowel syndrome * men with erectile dysfunction * married men Exclusion Criteria: * obese men * chest/renal disease men * cardiac/metabolic disease men * systemic disease men
Contact & Investigator
Ali MA Ismail
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT06783894 clinical trial?
This trial is open to male participants only, aged 30 Years or older, up to 50 Years, studying Irritable Bowel Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06783894 currently recruiting?
Yes, NCT06783894 is actively recruiting participants. Contact the research team at ali.mohamed@pt.cu.edu.eg for enrollment information.
Where is the NCT06783894 trial being conducted?
This trial is being conducted at Dokki, Egypt.
Who is sponsoring the NCT06783894 clinical trial?
NCT06783894 is sponsored by Cairo University. The principal investigator is Ali MA Ismail at Cairo University. The trial plans to enroll 40 participants.